Quick answer
As of September 26, 2026, the most common Zepbound (tirzepatide) side effects listed in the prescribing information are gastrointestinal: nausea, diarrhea, vomiting, constipation, abdominal pain and indigestion, plus injection site reactions, fatigue and hair loss. The label states that most nausea, vomiting and diarrhea events occurred during dose escalation and decreased over time. Serious but uncommon risks include pancreatitis, gallbladder disease, kidney injury from dehydration, severe allergic reactions, and low blood sugar with insulin or a sulfonylurea. Zepbound carries a boxed warning about thyroid C-cell tumors seen in rats and is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2. A precaution about suicidal behavior and ideation was removed from the label in February 2026.
What You Need to Know Up Front
If you're starting Zepbound, or thinking about it, you probably want straight answers about side effects. No medical jargon, no scare tactics, just an honest picture of what to expect.
Here's the truth: most people on Zepbound experience some side effects, especially during the first month or two. The most common ones are stomach issues like nausea, constipation, or diarrhea. They're usually mild to moderate, and they tend to fade as your body adjusts.
A smaller number of people run into more serious issues that need medical attention. We'll cover those too, because knowing the warning signs is exactly how you stay safe on this medication.
The good news: in the SURMOUNT-1 trial (NEJM 2022) of the approved product, the large majority of participants stayed on treatment rather than stopping because of side effects. For the large majority, side effects were manageable enough to continue treatment.
What Is Zepbound?
Zepbound is the brand name for tirzepatide when prescribed for chronic weight management. It was FDA-approved in November 2023, in combination with a reduced-calorie diet and increased physical activity, for adults with obesity, or adults with overweight who have at least one weight-related condition.
Tirzepatide is a dual GLP-1 / GIP receptor agonist, it activates two gut hormone receptors that work together to regulate blood sugar, appetite, and gastric emptying. The medication is given as a once-weekly subcutaneous injection. The label lists the abdomen, the thigh and the upper arm as injection areas; see where to inject Zepbound. For a head-to-head comparison with semaglutide, see Tirzepatide vs Semaglutide.
The Side Effects Most People Experience
In the clinical trials summarized in the prescribing information, here's roughly how often people ran into the most common side effects. Most of these are mild, most resolve in weeks, and most don't stop people from continuing the medication.
*Stomach-related (the big ones):*
- Nausea: about 1 in 4 people
- Diarrhea: about 1 in 5
- Constipation: about 1 in 7
- Vomiting: about 1 in 10
- Stomach pain or indigestion: about 1 in 10
- Burping more than usual: about 1 in 20
*Other things people sometimes notice:*
- A bit of tiredness during the first weeks
- A red bump or itch where you inject (a small minority of people)
- A reduced appetite, which is, of course, the point of the medication
Why is nausea so common?
Here's what's actually happening. Zepbound slows down how quickly food leaves your stomach. That's part of why you feel full longer and eat less, it's the medication doing its job. But it also means a heavy or greasy meal can sit in your stomach longer than your body's used to, which causes that queasy feeling.
The fix isn't dramatic. Smaller meals, lighter foods, and staying upright for half an hour after you eat usually solve it within a few weeks.
The Less Common Side Effects
A smaller group of people experience these. They're not rare, but they're not guaranteed either:
- Heartburn or acid reflux, same reason as the nausea, food sitting longer
- Hair shedding. The prescribing information lists it as a side effect and notes it was associated with weight reduction. Mention it to your doctor if it continues.
- Headaches during the first weeks
- Lightheadedness or dizziness, often from not drinking enough water
- A small increase in resting heart rate, just a few beats per minute
- Mood changes, some people report feeling more anxious or down, especially in the first weeks. This is worth mentioning to your doctor.
If you do experience hair shedding, ask your doctor whether your protein intake and your iron, zinc, and vitamin D levels should be checked.
The Serious Side Effects to Know About
These are uncommon, but you need to know what they look like so you can act quickly if they happen. They're the reason a real doctor (not just a website form) needs to be involved in your care.
Pancreatitis is inflammation of the pancreas. The Medication Guide directs patients to stop Zepbound and contact their healthcare provider immediately for severe abdominal pain that does not go away, with or without nausea or vomiting; the pain may extend to the back. Seek urgent medical assessment and do not wait for a routine follow-up. Zepbound Medication Guide.
Gallbladder problems can show up as sharp pain in your upper-right abdomen, especially after fatty meals, sometimes with fever or yellowing skin. Rapid weight loss, from any cause, not just GLP-1s, raises gallstone risk. If you have a history of gallbladder issues, tell your doctor up front.
Dehydration and kidney problems. Nausea, vomiting and diarrhea can cause fluid loss and kidney injury. Contact your healthcare provider right away if these symptoms do not go away. Seek urgent care if you cannot keep fluids down or feel extremely weak or faint; report reduced urination as well. Do not wait a fixed number of hours or try to manage severe dehydration with drinks alone. Your prescriber should decide whether the treatment plan needs to change. Zepbound Medication Guide, NIDDK warning signs.
Allergic reactions are rare but possible. The serious version: swelling of your face, lips, or tongue, or difficulty breathing. That's an emergency, call 911.
Mood changes. Earlier versions of the prescribing information carried a precaution about suicidal thoughts; that precaution was removed from the label in February 2026. Even so, if your mood gets noticeably worse on the medication, especially if you have any history of depression, tell your doctor right away. Don't tough it out.
Low blood sugar is mostly a concern if you're already taking other diabetes medications like insulin. Your doctor adjusts those when prescribing Zepbound. Signs: shakiness, sweating, confusion, fast heartbeat.
The Important Warning About Thyroid Risk
Zepbound carries the FDA's strongest type of warning, a "boxed warning", because in rat studies, tirzepatide caused a specific type of thyroid tumor. Whether this risk transfers to humans is not known. No clear connection has been found in human studies, but the warning exists out of caution. The oral GLP-1 tablet orforglipron carries the same class warning even though its own label states it did not produce tumors in rodents, a contrast set out in our guide to how the same thyroid warning reads on the orforglipron label.
Zepbound is not safe for people with:
- A personal or family history of medullary thyroid cancer
- A condition called MEN2 (Multiple Endocrine Neoplasia syndrome type 2)
This is exactly the kind of thing a real doctor screens for during your medical assessment. If your doctor doesn't ask about your family medical history, that's a red flag about the quality of care you're getting.
Signs to watch for once you're on the medication:
- A new lump or swelling in your neck
- Hoarseness that won't go away
- Difficulty swallowing
- Shortness of breath
If you notice any of those, tell your doctor.
How the Dose Schedule Works (and Why It Matters)
You don't start Zepbound at full strength. You start at a low dose and slowly work your way up over months. This isn't bureaucracy, it's the single most important thing you can do to keep side effects manageable.
The starting dose, how long each step lasts and the maintenance options are set out in the Zepbound prescribing information, and the schedule you actually follow is set by your prescriber.
You don't have to reach the maximum dose. The prescribing information lists more than one maintenance dose. Your doctor adjusts based on what's actually working for you, not based on a textbook target.
How to Manage the Common Side Effects
What you should do depends on your symptoms and any warning signs.
*For mild nausea without warning signs:*
- Try small portions of plain foods and small sips of clear liquids.
- Avoid food smells or greasy, heavily spiced foods if they worsen symptoms.
- Rest quietly and remain upright after eating.
These are general comfort suggestions, not remedies proven in tirzepatide trials. Contact your healthcare provider immediately about nausea, vomiting, or diarrhea that continues; severe or rapidly worsening symptoms need urgent care. MedlinePlus nausea self-care, Zepbound Medication Guide.
See the tirzepatide nausea guide: warning signs and questions for your clinician for trial findings, the limits of symptom timing, and a private symptom-report checklist.
*For diarrhea:*
- Replace fluids with something that has electrolytes (Pedialyte, Liquid IV, even Gatorade in a pinch)
- During flare-ups: bananas, rice, applesauce, and toast are gentle
- Avoid spicy foods, lots of caffeine, and sugar-free products with sorbitol or xylitol, they often make it worse
*For constipation:*
- More fiber, gradually, vegetables, beans, oatmeal, berries
- Follow any fluid instructions from your care team; ask if you are unsure how much to drink.
- A daily 30-minute walk genuinely helps
- If constipation persists, ask your clinician or pharmacist which options fit your symptoms, medical history and other medicines before starting a laxative or supplement.
For acid reflux or heartburn:
- For symptoms at night or while lying down, leaving at least three hours between a meal and lying down may help. NIDDK reflux eating guidance, reviewed July 2020 and checked October 11, 2026, gives this general advice; it is not a guaranteed or tirzepatide-specific result.
- Notice which foods or drinks coincide with your own symptoms and discuss that pattern with your clinician rather than removing every possible trigger.
Our focused tirzepatide heartburn guide separates reflux from indigestion and belching, explains warning signs, and includes a private worksheet for your prescriber.
*For the injection bump:*
- Rotate where you inject (belly, thigh, upper arm, different spot each week)
- Use a fresh needle each time
For hair shedding
Ask your clinician to assess the timing, pattern, scalp symptoms, and any difficulty eating enough. Tests should follow the history and examination; everyone does not need the same laboratory panel. A general shedding pattern does not prove a medicine is the cause or guarantee recovery. AAD: diagnosis and treatment.
For a closer look at hair loss during tirzepatide treatment, see what the Zepbound studies report, what those findings cannot tell you, and which changes to discuss with your clinician.
When to Call Your Doctor (and When to Go to the ER)
You don't have to call about every minor symptom. But here's a clear guide for when something needs medical attention.
*Contact your healthcare provider promptly if:*
- Nausea, vomiting or diarrhea does not go away. If you cannot keep fluids down, seek urgent care instead of waiting for a routine reply.
- You develop a new rash, hives, or itching
- Your heart feels like it's racing or skipping
- You feel lightheaded or like you might faint
- The injection spot is large, hot, or painful (not just a small bump)
*Go to the ER immediately if:*
- You cannot keep fluids down, especially with extreme weakness or fainting.
- You have severe stomach pain, especially if it shoots through to your back
- You have severe upper-right belly pain along with a fever
- Your face, lips, or tongue is swelling, or you're having trouble breathing
- You feel severely confused or you faint
- You're having thoughts of harming yourself or others
Don't tough it out. The downside of calling your doctor about something small is nothing. The downside of waiting on something serious can be major.
What We Know About Long-Term Use
Tirzepatide has been studied in trials going up to 88 weeks. Here's what the research shows:
- The same side effects. In the 88-week maintenance trial, the most common adverse events were again mostly mild to moderate stomach-related ones.
- Heart outcomes are still being studied. Long-term cardiovascular outcomes in people with obesity are being studied in a dedicated trial (SURMOUNT-MMO), so that evidence is not yet in.
- Continued treatment maintained weight loss in the maintenance trial (SURMOUNT-4): people who kept taking the medication held on to their weight loss and lost a little more.
- Stopping the medication usually leads to weight regain. In one study, people who stopped tirzepatide regained a substantial share of their lost weight over the next year; the figures are in the publication.
The honest implication: GLP-1 medications are usually used long-term, similar to blood pressure or cholesterol medications. They're not a 3-month fix. If your goal is sustained weight loss, you and your doctor should plan for ongoing treatment, not a sprint.
How to Start Zepbound Safely
The single most important thing you can do to minimize side effects? Work with a real licensed doctor. Not a 30-second online quiz. Not a foreign pharmacy that ships without a prescription. A US-licensed physician who reviews your full medical history, screens for contraindications, picks the right starting dose, and is available when you have questions.
Whoever you choose to work with, hold them to that standard: a named, licensed physician who takes your history seriously and stays reachable through treatment.
What the primary sources say
- DailyMed, U.S. National Library of Medicine, ZEPBOUND (tirzepatide) injection prescribing information, section 6.1 Clinical Trials Experience (accessed September 26, 2026): "The majority of nausea, vomiting, and/or diarrhea events occurred during dose escalation and decreased over time."
- PubMed Central, National Library of Medicine, Aronne LJ et al., SURMOUNT-4 Randomized Clinical Trial (JAMA, 2024) (accessed September 26, 2026): "In participants with obesity or overweight, withdrawing tirzepatide led to substantial regain of lost weight, whereas continued treatment maintained and augmented initial weight reduction."
- U.S. Food and Drug Administration, FDA News Release of November 08, 2023, FDA Approves New Medication for Chronic Weight Management (accessed September 26, 2026): "Zepbound causes thyroid C-cell tumors in rats. It is unknown whether Zepbound causes such tumors, including medullary thyroid cancer, in humans. Zepbound should not be used in patients with a personal or family history of medullary thyroid cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2."
- MedlinePlus Drug Information, Tirzepatide Injection (accessed September 26, 2026): "Tirzepatide injection also slows the emptying of the stomach and may decrease appetite and cause weight loss."
- National Institute of Diabetes and Digestive and Kidney Diseases, Prescription Medications to Treat Overweight and Obesity (accessed September 26, 2026): "You can keep taking these medications as long as you are benefiting from treatment and not experiencing serious side effects."
The primary sources for this article are listed below. This article is for informational purposes only and does not constitute medical advice. Results vary. Always consult a licensed physician.
Related guides
For the narrower question of unpleasant-smelling belching, see sulfur burps on tirzepatide: what is documented and when to seek care.
Frequently Asked Questions
How long do Zepbound side effects last?
Most common side effects (nausea, diarrhea, constipation) typically peak during dose escalation and ease over time as your body adapts. Some patients notice a flare-up with each dose increase that usually settles once they are established on the new dose.
What is the most common Zepbound side effect?
Nausea is the most common side effect, reported by roughly one in four participants in the trials of the approved product. It is typically mild-to-moderate and improves with dietary adjustments (smaller meals, less fat) and adequate hydration.
Can Zepbound cause permanent side effects?
The vast majority of Zepbound side effects are reversible and resolve when the medication is stopped or dose-reduced. Rare serious complications (pancreatitis, gallbladder disease, severe allergic reactions) can have lasting consequences and require immediate medical attention.
Is it safe to take Zepbound long-term?
Tirzepatide has been studied in trials lasting up to 88 weeks, in which the most common adverse events were again mostly mild to moderate gastrointestinal ones. GLP-1 medications are typically intended for long-term use, similar to medications for chronic conditions. Long-term cardiovascular outcomes data from SURMOUNT-MMO is expected in 2027.
Why am I nauseous on Zepbound?
Zepbound slows gastric emptying, food stays in your stomach longer. This is part of how the medication reduces hunger, but it can also cause nausea, especially when eating large meals or high-fat foods. Smaller, lower-fat meals typically reduce nausea significantly.
What foods should I avoid on Zepbound?
Avoid or limit high-fat fried foods, large portion sizes, sugar alcohols (sorbitol, xylitol), heavy alcohol, carbonated drinks, and very spicy foods. Focus on lean protein, vegetables, complex carbs in moderate portions, and adequate water.
Will I have side effects switching from Wegovy to Zepbound?
Switching can temporarily cause GI side effects similar to starting a new GLP-1. The prescribing information calls for starting at the lowest dose and stepping up gradually; your physician decides how to handle the transition in your case.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.ZEPBOUND (tirzepatide) injection, prescribing information, Eli Lilly and Company, SPL version 40, published Sep 02, 2026 (Boxed Warning) · DailyMed, U.S. National Library of Medicine · accessed
- 2.Drugs@FDA: FDA-Approved Drugs, NDA 217806 ZEPBOUND, Approval Date(s) and History · U.S. Food and Drug Administration · accessed
- 3.Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PMID 35658024 (SURMOUNT-1), PubMed record via NCBI E-utilities · PubMed, National Library of Medicine, NIH · accessed
- 4.Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38-48. PMCID PMC10714284 · PubMed Central, National Library of Medicine, NIH · accessed
- 5.NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO), ClinicalTrials.gov record (API v2; human-readable page at https://clinicaltrials.gov/study/NCT05556512) · ClinicalTrials.gov, National Library of Medicine, NIH · accessed
- 6.FDA News Release, November 08, 2023: FDA Approves New Medication for Chronic Weight Management · U.S. Food and Drug Administration · accessed
- 7.Tirzepatide Injection · MedlinePlus Drug Information, U.S. National Library of Medicine · accessed
- 8.Prescription Medications to Treat Overweight and Obesity · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
- 9.Zepbound prescribing information, revised August 2026 · Eli Lilly and Company · accessed
- 10.Zepbound Medication Guide, revised August 2026 · Eli Lilly and Company · accessed
- 11.Symptoms & Causes of Gastroparesis: urgent digestive symptoms and dehydration warning signs, last reviewed January 2018 · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
Telehealth prescribing rules differ by state. Read the state-by-state guide.
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them
